122
Views
21
CrossRef citations to date
0
Altmetric
Review

Pharmacotherapy of pompholyx

&
Pages 1517-1522 | Published online: 25 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Uwe Wollina. (2009) Pompholyx or dyshidrosis. Expert Review of Dermatology 4:4, pages 403-411.
Read now
Uwe Wollina. (2008) Pompholyx: what's new?. Expert Opinion on Investigational Drugs 17:6, pages 897-904.
Read now
Uwe Wollina, Gesina Hansel, André Koch & Mohamed Badawy Abdel-Naser. (2006) Topical pimecrolimus for skin disease other than atopic dermatitis. Expert Opinion on Pharmacotherapy 7:14, pages 1967-1975.
Read now

Articles from other publishers (18)

F. Ludwig. 2023. Facharztprüfung Allgemeinmedizin. Facharztprüfung Allgemeinmedizin 491 527 .
Fabian Ludwig. 2022. Facharzt Allgemeinmedizin. Facharzt Allgemeinmedizin 343 360 .
Thomas Bieber. 2017. Braun-Falco's Dermatologie, Venerologie und Allergologie. Braun-Falco's Dermatologie, Venerologie und Allergologie 1 10 .
Thomas Bieber. 2018. Braun-Falco’s Dermatologie, Venerologie und Allergologie. Braun-Falco’s Dermatologie, Venerologie und Allergologie 569 578 .
Jeewanjit Gill & Melanie Pratt. (2015) A Severe Case of Recalcitrant Pompholyx. Journal of Cutaneous Medicine and Surgery 19:5, pages 494-497.
Crossref
D.C. Soler, X. Bai, L. Ortega, T. Pethukova, S.T. Nedorost, D.L. Popkin, K.D. Cooper & T.S. McCormick. (2015) The key role of aquaporin 3 and aquaporin 10 in the pathogenesis of pompholyx. Medical Hypotheses 84:5, pages 498-503.
Crossref
D. I. Laseev, O. V. Dikova, M. G. Laseeva & A. L. Kovalenko. (2015) Assessment of the efficacy of a metabolic drug in combined therapy of eczema. Klinicheskaya dermatologiya i venerologiya 14:2, pages 48.
Crossref
C. Skudlik, B. Lindemann, M. Woltjen, S. Brandenburg & S.M. John. (2013) „Mit allen geeigneten Mitteln““With all suitable means”. Der Hautarzt 64:10, pages 743-747.
Crossref
Thomas Bieber. 2012. Braun-Falco’s Dermatologie, Venerologie und Allergologie. Braun-Falco’s Dermatologie, Venerologie und Allergologie 529 538 .
. (2012) Pompholyx, a common palmoplantar skin disorder, usually requires a combination of topical and systemic therapy. Drugs & Therapy Perspectives 27:4, pages 18-20.
Crossref
Uwe Wollina. (2010) Pompholyx. American Journal of Clinical Dermatology 11:5, pages 305-314.
Crossref
Sunil Chopra, Mario A. Knight & Francisco Vega-Lopez. 2009. Manson's Tropical Diseases. Manson's Tropical Diseases 333 371 .
Thomas Bieber. 2009. Braun-Falco’s Dermatology. Braun-Falco’s Dermatology 425 433 .
Lorivaldo Minelli, Ryssia Alvarez Florião, Manoel Sternick & Airton dos Santos Gon. (2008) Disidrose: aspectos clínicos, etiopatogênicos e terapêuticos. Anais Brasileiros de Dermatologia 83:2, pages 107-115.
Crossref
Johannes Ring, Matthias Möhrenschlager & Verena Henkel. (2008) The US FDA ‘Black Box’ Warning for Topical Calcineurin Inhibitors. Drug Safety 31:3, pages 185-198.
Crossref
Uwe Wollina. (2007) The Role of Topical Calcineurin Inhibitors for Skin Diseases Other Than Atopic Dermatitis. American Journal of Clinical Dermatology 8:3, pages 157-173.
Crossref
Sabra M. Lofgren & Erin M. Warshaw. (2006) Dyshidrosis: Epidemiology, Clinical Characteristics, and Therapy. Dermatitis 17:4, pages 165-181.
Crossref
J.-M. Lachapelle. (2006) La dysidrose: cent fois sur le métier, remettez votre ouvrage. Annales de Dermatologie et de Vénéréologie 133:2, pages 113-116.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.